HLA Peptide Target Discovery – Mitigating Risk in Target Selection

In this webinar, members of the Pure MHC research team present and discuss data and learnings drawn from decades of experience identifying and validating HLA peptide targets for therapeutic development. Special emphasis was be given to mitigating risk in preclinical target selection for oncology and infectious disease indications.


  • Target Discovery in Infectious Disease: West Nile Virus Case Study
  • Tools for Receptor Value
  • Oncology Therapeutic Proof of Concept: Melanoma Case Study
  • Ovarian Cancer Oncology Case Study
  • Summary of Risk Mitigation Through Pure MHC Target Discovery Methods

To access the pre-recorded webinar, please email info@puremhc.com and type “Webinar” in the subject line. A link to the webinar will be emailed to you.

Thank you for registering, we have sent an email with a link to the webinar to the address provided.